JAMES CAMPBELL: Open Payments
NPI 1720091077 · BROKEN ARROW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,884 in 196 payments from 31 companies in 2025. Trend: 2023 $5,465 · 2024 $5,417 · 2025 $5,884
Food & beverage: $5,842Education: $43
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $766 |
| Vanda Pharmaceuticals Inc. | 26 | $580 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $564 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $481 |
| Intra-Sana Laboratories | 12 | $455 |
| ABBVIE INC. | 18 | $449 |
| Amgen Inc. | 11 | $333 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $299 |
| Noven Therapeutics, LLC | 12 | $287 |
| Boston Scientific Corporation | 8 | $269 |
Products named: FANAPT, CAPLYTA, JARDIANCE, RELTONE 200 MG, AIRSUPRA, Kerendia, Xelstrym, BREZTRI.
Industry payments across OK — which companies pay providers there.
